Thomas Uldrick, MD

Please share this fact sheet about Ukraine with anyone who needs it

THREAD: Trump's intentionally flooding the zone w/ a stream of outrage porn like calling himself "king" to distract you. Here's the stories that actually matter that you might've missed this week: NIH funding cuts jeopardize ‘life-saving’ research in AL aldailynews.com/nih-funding-cu…

I wrote up an FAQ about the recent federal grant cuts. A few key points 🧵:

"Keeping the CDC and EIS personnel fully staffed can actually reduce costs in the long-run by early detection and prevention of many potential public health threats."

1/ After residency at Mass General Hospital, I reported to Atlanta to meet my fellow CDC Epidemic Intelligence Service Officers. I have never felt so intimidated by my peers The best and the brightest, they were star clinicians, had served in disaster zones; MD/PhDs and MSF.

New #JITC article: Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma bit.ly/4hTppa7 @DrKateLurain @Fluffone @ThomasUldrick @theNCI @fredhutch

Efficiency in government should be a goal for every administration, agency, and federal employee. But how we achieve it also matters. By circumventing proper channels and procedures, and creating the potential to compromise the sensitive data of Americans, we create a tremendous amount of unnecessary anxiety. That is wrong. Good governance is based on trust, not fear.

PEL-PS is a new validated prognostic score predicting OS in #HIV+ Primary Effusion #Lymphoma using ECOG and hemoglobin Good PEL-PS (Hb ≥8 g/dL and ECOG ≤2) had median OS >10 years doi.org/10.1002/ajh.27…

Congrats to the C-POST team on the positive interim results from this well designed and rigorously conducted study!

A lot of misinformation out there. Just launched a new site to ensure the public has access to fact-based data around the Southern CA wildfires. The TRUTH: - CA did NOT cut our firefighting budget. We have nearly doubled the size of our firefighting army and built the world’s largest aerial firefighting fleet. - CA has INCREASED forest management ten-fold since we took office. - California will NOT allow for looting. Get the facts: californiafirefacts.com

wow!

New research from @ThomasOdeny and team highlights the promise of immunotherapy for HIV-associated Kaposi sarcoma in treating KS in people living with HIV. #CancerResearch #HIV #Immunotherapy #KaposiSarcoma Read More: ascopubs.org/doi/10.1200/JC…

@wagsmd @JCO_ASCO @DrKateLurain @EladSharonMD Thanks for contributing to this study!!!

IO can be safe and effective for HIV-KS. CITN12: Pembrolizumab in HIV-Associated Kaposi Sarcoma | ⁦@JCO_ASCO⁩ ⁦@DrKateLurain⁩ ⁦@EladSharonMD⁩ ⁦@ThomasUldrick⁩ ascopubs.org/doi/10.1200/JC…

@EladSharonMD @AaronGoodman33 @NCItreatment @NCIResearchCtr @fredhutch @theNCI @JCO_ASCO @Dr_R_Kurzrock There was equipoise about anti-pd1 in HIV-KS. NCCN only supports in classic KS. Our 29 person prospective study has similar est of benefit to the 9 patent retrospective experience. Growing evidence will hopefully increase impact of findings for HIV KS patients, which matters!

@AaronGoodman33 @NCItreatment @NCIResearchCtr @fredhutch @theNCI @JCO_ASCO @Dr_R_Kurzrock I know the paper, but prospective trials are still important! ncbi.nlm.nih.gov/pmc/articles/P…

Extremely proud of this @NCItreatment-sponsored effort with @NCIResearchCtr and #CITN investigators showing extremely high response rates of #pembrolizumab in #HIV-associated #KaposiSarcoma! One of the highest response rates of #PD1 in a solid tumor! @fredhutch @theNCI @JCO_ASCO

Hot off the press from @DrKateLurain @ramya_ramaswami @ThomasOdeny @EladSharonMD @DiseaseDR Important new data showing high and durable activity for anti-PD1 in HIV-KS! CITN12: Pembro in HIV-Associated Kaposi Sarcoma | JCO ascopubs.org/doi/10.1200/JC…

We are full of grief with the loss of a dear friend and a beautiful, courageous person, wife, mother, physician, and advocate for improving care for all, Dr. Shekinah Elmore (HROP class of 2020).

Congrats to the amazing Dr Dr. D!

@DJPinato @imperialcollege @UniAvogadro @ALEDIGNUS12 @A_DAlessioMD @profbower @MarkYarchoan @MdCurioni @FulgenziClaudia @CiroCelsa @ACortelliniMD congrats! Well deserved.

As ‘23 draws to an end and out of office reply is solidly on I’d like to celebrate my promotion to Clinical Reader/Associate Professor👨‍🎓 @imperialcollege @UniAvogadro Busy HCC agenda in ‘24 Starting strong with a joint vision from 2 institutions willing to make a difference 👨‍🔬

Wish I were @ASH to see @DrKateLurain et al's important rb.gy/5f7c6d on CATCH-IT RWE for anti-PD1 in #HIV #Hodgkin #lymphoma today. Encouraging activity after med 2nd line Tx in EBV+ disease (unique biology in HIV ): 70% CR rate, 20 mo DOR including in low CD4!

Congrats @keithsigelmd !